DIVITA CHARLES III 4

What Happened

• Charles Divita III, CEO of Teladoc Health (TDOC), reported conversions/exercises of equity awards on June 10, 2026 that resulted in the acquisition of 42,802 shares (3,642 and 39,160 reported in separate conversion entries). Corresponding derivative disposition entries were reported at $0 (reflecting conversion/settlement of awards).
• On June 11, 2026 he sold 18,074 shares in an open-market transaction at $6.94 per share, generating $125,470. Footnotes indicate the sale was to cover the tax withholding obligation related to vesting of the performance stock units (PSUs) and restricted stock units (RSUs).

Key Details

• Transaction dates: June 10, 2026 (conversion/exercise of awards) and June 11, 2026 (open-market sale).
• Sale price and proceeds: 18,074 shares sold at $6.94 for $125,470.
• Shares acquired via conversion/exercise: 3,642 and 39,160 (total 42,802) reported as "M" (exercise/conversion of derivative).
• Shares owned after the transactions: not specified in the supplied filing details.
• Relevant footnotes:
  • F1/F2: PSUs and RSUs convert to TDOC common stock one-for-one.
  • F3: The 18,074-share sale was to cover tax withholding on vesting awards.
  • F4: On June 10, 2026, the reporting person earned 23,591 PSUs with a multi-period vesting schedule.
  • F5: On June 10, 2024, the reporting person received 469,924 RSUs with a staggered vesting schedule.
• Filing: Report filed June 12, 2026 for transactions dated June 10–11, 2026. No late-filing indication provided in the supplied data.

Context

• The "M" code denotes exercise/conversion of derivatives (here, conversion of PSUs/RSUs to common shares). Disposition entries showing $0 are typical when awards convert/settle rather than generating cash proceeds.
• The open-market sale was reported as a sale to cover tax withholding tied to vesting—this is a routine administrative sale and not necessarily an indicator of broad insider sentiment.